Canavan Disease

Canavan disease is an autosomal recessive degenerative disorder that causes progressive damage to nerve cells in the brain, and is one of the most common degenerative cerebral diseases of infancy. Discover the latest research on Canavan disease here.

July 6, 2020

Structural network efficiency predicts cognitive decline in cerebral small vessel disease

NeuroImage. Clinical
Esther M BootAnil M Tuladhar
June 27, 2020
Open Access

Leukoencephalopathy Associated with Severe COVID-19 Infection: Sequela of Hypoxemia?

AJNR. American Journal of Neuroradiology
M LangS P Rincon
July 3, 2020
Open Access

Suitability of external controls for drug evaluation in Duchenne muscular dystrophy

Neurology
Nathalie Goemansinvestigators from PRO-DMD-01 study, CINRG DNHS, ImagingDMD, and The DMD Italian Group
July 3, 2020
Review
Open Access

On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19

Journal for Immunotherapy of Cancer
Thilo GambichlerJürgen Christian Becker
July 9, 2020
Open Access

COX deficiency and leukoencephalopathy due to a novel homozygous APOPT1/COA8 mutation

Neurology. Genetics
Carola Hedberg-OldforsAnders Oldfors
July 9, 2020
Open Access

Nonreciprocal Metamaterial Obeying Time-Reversal Symmetry

Physical Review Letters
Siddharth BuddhirajuShanhui Fan
July 10, 2020
Case Report

Van der Knaap Disease (Vanishing White Matter) - Unusual Presentation in a Neonate: A Case Report

Neurology India
Malay JhancyReshme Ahamed
July 2, 2020

MZT Proteins Form Multi-Faceted Structural Modules in the γ-Tubulin Ring Complex

Cell Reports
Michal WieczorekTarun M Kapoor
July 10, 2020
Case Report

Nivolumab for Treatment of Progressive Multifocal Leukoencephalopathy in Sézary Syndrome

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Niklas GrasslPhilipp Eisele
July 10, 2020
Review
Open Access

Abdominal neoplastic manifestations of neurofibromatosis type 1

Neuro-oncology Advances
Anna J DareRebecca A Gladdy
July 9, 2020

Intravenous milrinone in posterior reversible Leucoencephalopathy Syndrome

Revue neurologique
L LucasI Sibon
July 9, 2020

Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis

Journal of Clinical Immunology
Annaliesse BlincoeElie Haddad
July 10, 2020
Case Report

A case of co-occurrence of radiation-induced leukoencephalopathy and CADASIL

Neurology. Clinical Practice
Laura Donker KaatSaskia A M J Lesnik Oberstein
July 10, 2020

Initial ophthalmic manifestation of a fatal underlying disease : Importance of perimetry in unspecific visual deterioration

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
J Orphal, N Terai
July 8, 2020

Optical coherence tomography in adult adrenoleukodystrophy: a cross-sectional and longitudinal study

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Stefania Bianchi-MarzoliEttore Salsano
July 8, 2020

Single-Cell Transcriptomic Analyses of the Developing Meninges Reveal Meningeal Fibroblast Diversity and Function

Developmental Cell
John DeSistoJulie A Siegenthaler

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/canavan-disease/e0efbc35-cec0-44f5-a5cd-74ff2c489c22